BAKX Therapeutics
Kingston, New York, United States
BAKX Therapeutics is a New York and Boston based company focused on developing safer, more effective therapeutics that fully realize the potential of the mitochondrial apoptosis pathways. BAKX was co-founded by world leading researchers in the field of apoptosis and computationally aided drug discovery. The company’s leading asset BKX-001 (partnered with Ipsen) is focused on targeting the BAX protein. In addition, the BAKX platform is deployed towards drugging other undisclosed apoptosis targets implicated in various solid tumors and the build up of resistance.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.bakxtx.com
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of BAKX Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now